Zhang, Mingyue
Zheng, Zhuo
Xie, Xianfeng
Dai, Yuee
Zhao, Maosen
Gao, Ke
Liu, Shaoxing
Funding for this research was provided by:
Sichuan Medical Association’s Research in the fields of oncology, anesthesia Program (SC202402)
Sichuan Science and Technology Program (2022YFS0439)
Health Commission of Sichuan Province Medical Science and Technology Program (2022-217)
Article History
Received: 15 November 2024
Accepted: 7 July 2025
First Online: 8 August 2025
Declarations
:
: This study was conducted following the evaluation and approval of the Ethics Committee of the Second People’s Hospital of Chengdu (Chairperson Prof Ruoxi Zhang) on 31 May 2024, with the specified study period being (Ethics Approval Number: 2024335). This study was registered at ClinicalTrials.gov (ChiCTR2400086348) and adheres to the applicable Equator guidelines. Informed consent was obtained from all participants, who were made aware of their rights, including the right to withdraw from the study at any point.
: Not applicable.
: The authors declare no competing interests.